Sleep Aids Market (By Product: Mattresses & Pillows, Medications, Sleep Apnea Devices, Others; By Sleep-Disorder: Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking, Other Sleep Disorders)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Sleep Aids market size was estimated at USD 74.3 billion in 2021 and is expected to surpass around USD 124.97 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 5.95% during the forecast period 2022 to 2030.

Key Takeaways:

  • The sleep laboratories segment is expected to grow at a CAGR of 8.3% from 2022 to 2030.
  • The restless legs syndrome segment is predicted to grow at a CAGR of 8.1% from 2022 to 2030.
  • Asia-Pacific region is anticipated to reach at a CAGR of 9.4% over the forecast timeframe from 2022 to 2030.

Sleep disorders are the conditions that impair the sleep pattern or disturb the restful sleep and as a result it can cause daytime sleepiness and other symptoms. It can have several symptoms such as regular experience of difficulty sleeping, tiredness during the day even though sleeping for at least seven hours the night before, reduced or impaired ability to perform regular daytime activities. Not getting enough sleep can have untoward consequences on school &work performance, interpersonal relationships, thinking, mental health, weight and the development of diabetes and heart disease. 

The common sleep disorders include insomnia, restless legs syndrome, narcolepsy and sleep apnea. The sleep disorders can be treated with the treatment options such as counseling, medications & supplements like melatonin, zolpidem, zaleplon, eszopiclone, ramelteon, suvorexant, lamborexant, gabapentin, and number of stimulants or wake-promoting medications, such as modafinil, armodafinil and pitolisant. Moreover, regular exercise and proper management of noise, light and temperature at the place also help in sleep impair. Various sleeping aids also can contribute in the treatment of sleep disorders.

The growth of the sleep aids market is driven by the benefits of using sleep aids products and rise in disposable income. Moreover, the surge in the geriatric and obese population has led to an increase in the cases of sleep disorder, which is anticipated to increase the patient population with sleep disorders that contribute toward the growth of the market. However, the side effects of sleep aids medication on human health and large number of patent expiration of medication are expected to hinder the sleep aids market growth. Conversely, the advancement of sleep aids product helps to increase the adoption rate and the untapped market in developing economies, which are expected to offer lucrative opportunities for the growth of the market.

Report Scope of the Sleep Aids Market

Report Coverage

Details

Market Size in 2022

USD 78.72 Billion

Market Size by 2030

USD 124.97 Billion

Growth Rate from 2022 to 2030

CAGR of 5.95%

Base Year

2021

Forecast Period

2022 to 2030

Segments Covered

Product, Sleep-Disorder, Geography

Companies Mentioned

Acelity L.P. Inc. (Kinetic Concepts, Inc.), AstraZeneca Plc, Biodiem, Cadwell Industries Inc., Compumedics Limited, CSL Limited, Drive, Drive DeVilbiss Healthcare Inc., Eisai Co., Ltd., Emergent Biosolutions, F.Hoffmann-La Roche Ltd., Fisher & Paykel Healthcare Limited, Gamma Vaccines Pty Ltd., GlaxoSmithKline Plc., Koninklijke Philips N.V., Merck and Co. Inc., Natus Medical Incorporated, Novartis AG, Pfizer Inc., ResMed Inc., Sanofi S.A., Serta Simmons Bedding LLC, Sinovac Biotech Ltd., SleepMed Inc., Takeda Pharmaceutical Company Limited, Tempur Sealy International Inc.

 

Industry Dynamics

GrowthDrivers
The primary factor driving the growth of the sleeping aids market is the changing sleep pattern of the global population triggered by changing lifestyles. Further, the increasing affluence of the consumers coupled with the improved access to medical services on account of the rising demand for quality healthcare is anticipated to drive the market growth. Moreover, the growing approval of new products in the market and the increasing government funding for research & development are expected to offer huge sleep aids industry growth opportunities.

The increasing M&A (Merger & Acquisition) among industry players to expand their product portfolio and geographic presence are anticipated to drive the market growth. For instance, in September 2018, Tris Pharma acquired NextWave, a subsidiary of Pfizer. This acquisition is expected to expand Tris Pharma’s product portfolio for treating ADHD patients. Furthermore, the rising innovation in sleeping aids devices and the development of proper drugs for inappropriate sleep with fewer side effects are anticipated to boost the demand globally.

Product Insights

Pillows and Mattress sector dominated the market of a sleep aid with the major market share and it is expected to keep on dominant throughout the forecast. The mattresses & pillows are predicted to see disposition determined by the growing developments in industrial methods. Primary features driving segmental development like easy useableness & accessibility of a diversity of things and more alertness about the health assistances of excellent sleep. The increasing difficulties of sleeplessness will speed up the health association to grow new and further well-organized sleeping aids. The changing lifestyles of the people play an important role in the market growth of worldwide sleeping aids.

Sleep Disorder Insights

Depending on sleep disorders universal market for sleep aids is segmented into sleepwalking, narcolepsy, insomnia, restless leg disorder, sleep apnea, and other conditions. The part of Insomnia observed the major market share and is projected to lead the market of sleeping aids and its governance in the business during the period of forecast due to the growth in healthcare alertness, growing occurrence of sleeping apnea, reduction in a physical workout by the people, and progress in the geriatric people. Insomnia is a condition that causes trouble in staying or falling asleep. A huge portion of the sector can be credited to the growing occurrence of the disorder worldwide. The main causes of this condition like pain, depression, chronic stress, and others. Furthermore, another growth sponsor is budding treatment practice in this section. The segment of Sleep Apnea may display the highest development in the prediction period owing to the growing sleep apnea challenge.

Regional Insights

North America accounted for major share of the global sleep aids market share in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to increase in incidences of Sleep disorders such as sleep apnea, surge in demand for sleep aid devices, availability of advanced healthcare facilities with trained medical professionals, rise in number of R&D activities along with large presence of key players, and surge in investment made by governments in the healthcare system. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period. Moreover, Japan and China are expected to grow at high CAGR in Asia-Pacific sleep aid market majorly due to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced instruments, development of the R&D sector, rise in healthcare reforms, and technological advancements in the field of sleep aids.

Some of the prominent players in the Sleep Aids Market include:

  • Acelity L.P. Inc. (Kinetic Concepts, Inc.)
  • AstraZeneca Plc
  • Biodiem
  • Cadwell Industries Inc.
  • Compumedics Limited
  • CSL Limited
  • Drive
  • Drive DeVilbiss Healthcare Inc.
  • Eisai Co., Ltd.
  • Emergent Biosolutions
  • F.Hoffmann-La Roche Ltd.
  • Fisher & Paykel Healthcare Limited
  • Gamma Vaccines Pty Ltd.
  • GlaxoSmithKline Plc.
  • Koninklijke Philips N.V.
  • Merck and Co. Inc.
  • Natus Medical Incorporated
  • Novartis AG
  • Pfizer Inc.
  • ResMed Inc.
  • Sanofi S.A.
  • Serta Simmons Bedding LLC
  • Sinovac Biotech Ltd.
  • SleepMed Inc.
  • Takeda Pharmaceutical Company Limited
  • Tempur Sealy International Inc.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Sleep Aids market

By Product

  • Mattresses & Pillows
  • Medications
    • Prescription-based Drugs
    • OTC drugs
    • Herbal drugs
  • Sleep Apnea Devices
    • Positive Airway Pressure (PAP) Devices
    • Facial Interfaces
    • Oral Appliances
    • Adaptive Servo-Ventilators (ASVs) 
  • Others

By Sleep-Disorder

  • Insomnia
  • Sleep Apnea
  • Restless Legs Syndrome
  • Narcolepsy
  • Sleep Walking
  • Other Sleep Disorders

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Sleep Aids industry analysis from 2022 to 2030 to identify the prevailing Sleep Aids industry opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the global Sleep Aids industry segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis f the regional as well as global Sleep Aids industry trends, key players, market segments, application areas, and market growth strategies.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Sleep Aids Market 

5.1. COVID-19 Landscape: Sleep Aids Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Sleep Aids Market, By Product

8.1. Sleep Aids Market, by Product, 2022-2030

8.1.1. Mattresses & Pillows

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Medications

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Sleep Apnea Devices

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Sleep Aids Market, By Sleep-Disorder

9.1. Sleep Aids Market, by Sleep-Disorder, 2022-2030

9.1.1. Insomnia

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Sleep Apnea

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Restless Legs Syndrome

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Narcolepsy

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Sleep Walking

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Other Sleep Disorders

9.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Sleep Aids Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Product (2017-2030)

10.1.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.1.3.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.1.4.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.3.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.4.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.5.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

10.2.6.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.3.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.4.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.5.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

10.3.6.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.3.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.4.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.5.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

10.4.6.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Product (2017-2030)

10.5.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Product (2017-2030)

10.5.3.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Product (2017-2030)

10.5.4.2. Market Revenue and Forecast, by Sleep-Disorder (2017-2030)

Chapter 11. Company Profiles

11.1. Acelity L.P. Inc. (Kinetic Concepts, Inc.)

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. AstraZeneca Plc

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Biodiem

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Cadwell Industries Inc.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Compumedics Limited

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. CSL Limited

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Drive

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Drive DeVilbiss Healthcare Inc.

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Eisai Co., Ltd.

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Emergent Biosolutions

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers